Evaluating Risk of Recurrent Venous Thromboembolism During the Anticoagulation Period in Patients with Malignancy
Background - Current guidelines suggest that all cancer patients with venous thrombosis be treated with long-term low molecular weight heparin. Whether treatment strategies should vary according to clinical characteristics remains unknown. // Systematic review - A systematic review was performed to...
Main Author: | |
---|---|
Other Authors: | |
Language: | en |
Published: |
Université d'Ottawa / University of Ottawa
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/19827 http://dx.doi.org/10.20381/ruor-4465 |
Search Result 1
Search Result 2
Search Result 3